Physician profile
Kishore Kumar
NPI 1205084399
$685.20
in general payments reported to CMS, 2019-2025
10 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $50.06 · 2021: $250 · 2024: $133 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $175.05 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $148.60 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $69.86 | 2024 | |
| Merck Sharp & Dohme LLC | $63.55 | 2025 | Verquvo |
| Paratek Pharmaceuticals, INC. | $59.01 | 2025 | Nuzyra |
| Boston Scientific Corporation | $49.46 | 2025 | Watchman Access System, General - Therapies |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.56 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $36.19 | 2025 | Eliquis |
| Solventum Corporation | $18.99 | 2025 | V.A.C.Ulta |
| Scpharmaceuticals INC. | $18.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kishore Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.